Growth Metrics

Eli Lilly (LLY) Debt Ratio (2016 - 2026)

Eli Lilly filings provide 18 years of Debt Ratio readings, the most recent being 0.37 for Q1 2026.

  • On a quarterly basis, Debt Ratio fell 13.66% to 0.37 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.37, a 13.66% decrease, with the full-year FY2025 number at 0.38, down 11.59% from a year prior.
  • Debt Ratio hit 0.37 in Q1 2026 for Eli Lilly, down from 0.38 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.43 in Q1 2025 to a low of 0.33 in Q4 2022.
  • Median Debt Ratio over the past 5 years was 0.37 (2026), compared with a mean of 0.38.
  • Biggest five-year swings in Debt Ratio: increased 20.11% in 2023 and later decreased 13.66% in 2026.
  • Eli Lilly's Debt Ratio stood at 0.33 in 2022, then increased by 20.11% to 0.39 in 2023, then increased by 8.45% to 0.43 in 2024, then dropped by 11.59% to 0.38 in 2025, then decreased by 1.55% to 0.37 in 2026.
  • The last three reported values for Debt Ratio were 0.37 (Q1 2026), 0.38 (Q4 2025), and 0.37 (Q3 2025) per Business Quant data.